Report of serious adverse drug reaction induced by anti-cancer agents
Inoue, A.
Nihon Rinsho. Japanese Journal of Clinical Medicine 73 Suppl. 2: 67-72
2015
ISSN/ISBN: 0047-1852 PMID: 25831726 Document Number: 684972
Document emailed within 1 workday
Related Documents
Knipping, W. 1980: Problems of evaluating rare adverse drug reactions using as an example agranulocytosis induced by anti-arrhythmia agents Medizinische Klinik 75(3): 108-115Yang, Y-Yin.; Dong, Z.; Xia, Y-Peng. 2012: Discussion on adverse reactions monitoring modes of drug manufacturers under new measures for administration of adverse drug reaction report and monitoring Zhongguo Zhong Yao Za Zhi 37(21): 3329-3333
Gram, L.F. 1977: Adverse effects during treatment with beta receptor blockaders. Report from the Adverse Drug Reaction Committee 1968-1976 Ugeskrift for Laeger 139(35): 2065-2068
Wang, D.; Du, X-Xi. 2012: Interpretation of adverse drug reaction reporting and monitoring and significance of traditional Chinese medicine adverse drug reaction monitoring Zhongguo Zhong Yao Za Zhi 37(18): 2686-2688
Tan, W.C.; Ong, C.K.; Kang, S.C.L.; Razak, M.A. 2007: Two years review of cutaneous adverse drug reaction from first line anti-tuberculous drugs Medical Journal of Malaysia 62(2): 143-146
Fushteĭ, I.M.; Torbin, E.S.; Polivoda, S.N. 1989: Drug-induced nephropathy and hemorrhagic cystitis as an adverse reaction to kanamycin Klinicheskaia Meditsina 67(8): 105
Shastri, V.; Betkerur, J.; Kushalappa, P.A.; Savita, T.G.; Parthasarathi, G. 2006: Severe cutaneous adverse drug reaction to leflunomide: a report of five cases Indian Journal of Dermatology Venereology and Leprology 72(4): 286-289
Lumholtz, I.B. 1981: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 16. (3). Anti-arrhythmia agents with action on ventricular arrhythmias Sygeplejersken 81(2): 15
Pantazis, P.; Han, Z.; Balan, K.; Wang, Y.; Wyche, J.H. 2003: Camptothecin and 9-nitrocamptothecin (9NC) as anti-cancer, anti-HIV and cell-differentiation agents. Development of resistance, enhancement of 9NC-induced activities and combination treatments in cell and animal models Anticancer Research 23(5a): 3623-3638
Takemoto, T.; Yanai, H. 1988: Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; problems on standardization of the appropriate time for the withdrawal of anti-ulcer agents Nihon Rinsho. Japanese Journal of Clinical Medicine 46(1): 133-139
Murano, S.; Saito, Y. 1992: Adverse reaction of anti-hypertensive drugs on sexual function Nihon Rinsho. Japanese Journal of Clinical Medicine 50 Suppl: 120-124
Porter, C.B.; Goldberg, A.T.; Fritts, K.W. 1981: Adverse reaction to a nonepinephrine hemostatic drug General Dentistry 29(2): 134-135
Kshirsagar, N.A.; Karande, S.C.; Potkar, C.N. 1993: Adverse drug reaction monitoring in India Journal of the Association of Physicians of India 41(6): 374-376
Deshpande, N.S. 1993: Adverse drug reaction monitoring of ciprofloxacin Indian Pediatrics 30(7): 942-943
Weisburger, J.H.; Weisburger, E.K.; Griswold, D.P.; Casey, A.E. 1968: Reduction of carcinogen-induced breast cancer in rats by an anti-fertility drug Life Sciences 7(5): 259-266
Lumholtz, I.B. 1980: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 14. Digitalis glycosides Sygeplejersken 80(50): 13
Nelson, R.W.; Shane, R. 1983: Developing an adverse drug reaction reporting program American Journal of Hospital Pharmacy 40(3): 445-446
Honorato, J.; Giráldez, J.; Mart'i Mass'o, R.; Fos, D.; Velasco, J.L.; S'anchez, H. 1976: Control of adverse drug reaction in a hospital environment Revista de Medicina de la Universidad de Navarra 20: 209-211
Juergens, J.P.; Banahan, B.F. 1986: Adverse drug reaction reporting by Mississippi physicians Journal of the Mississippi State Medical Association 27(2): 33-37
Prosser, T.R.; Kamysz, P.L. 1990: Multidisciplinary adverse drug reaction surveillance program American Journal of Hospital Pharmacy 47(6): 1334-1339